Iranian Scientists Produce Warfarin Drug for Cardiovascular Patients
17:00 - May 14, 2024

Iranian Scientists Produce Warfarin Drug for Cardiovascular Patients

TEHRAN (ANA)- Head of Iran’s Food and Drug Administration announced that the country’s scientists have achieved the technology to produce warfarin drug for cardiovascular patients.
News ID : 5946

“The first domestic producer of warfarin will distribute a large amount of the drug in the market in the coming days,” said Heider Mohammadi.

“Warfarin is a special drug and its production requires special conditions due to its limited therapeutic window, and one of the Iranian pharmaceutical companies has succeeded in producing the drug,” he added.

Mohammadi assured the cardiovascular patients that due to the imports of a suitable amount of warfarin drug and its domestic production no restrictions will exist on its supply in the next few months.

Warfarin is an anticoagulant (blood thinner). It reduces the formation of blood clots.

Warfarin is used to treat or prevent blood clots in veins or arteries, which can reduce the risk of stroke, heart attack, or other serious conditions.

The common side effect, a natural consequence of reduced clotting, is bleeding. Less common side effects may include areas of tissue damage, and purple toes syndrome.

4155/v

Send comment